NovaBay Pharma (NBY) Announces 1:35 Reverse Stock Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St choppy as megacap losses offset chip gains before Fed decision
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- S&P Global explores potential separation of Capital IQ business
- Wall Street ends higher on revived AI momentum
- SpaceX stock drops amid spaceport lawsuit, debt concerns
- Nebius Group shares jump after France data center funding
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
NovaBay Pharmaceuticals Announces 1-for-35 Reverse Stock Split
November 14, 2022 4:02 PM ESTEMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay® Pharmaceuticals, Inc. (the Company) (NYSE American: NBY) announces that today, following approval from the Companys stockholders obtained at the Companys November 10, 2022 special stockholders meeting, the Companys Board of Directors (the Board) has approved the filing of an amendment to the... More



